1. Home
  2. AZTR vs LGHL Comparison

AZTR vs LGHL Comparison

Compare AZTR & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • LGHL
  • Stock Information
  • Founded
  • AZTR 2014
  • LGHL 2015
  • Country
  • AZTR United States
  • LGHL Singapore
  • Employees
  • AZTR N/A
  • LGHL N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • LGHL Investment Bankers/Brokers/Service
  • Sector
  • AZTR Health Care
  • LGHL Finance
  • Exchange
  • AZTR Nasdaq
  • LGHL Nasdaq
  • Market Cap
  • AZTR 5.2M
  • LGHL 4.3M
  • IPO Year
  • AZTR 2023
  • LGHL N/A
  • Fundamental
  • Price
  • AZTR $0.30
  • LGHL $3.50
  • Analyst Decision
  • AZTR
  • LGHL
  • Analyst Count
  • AZTR 0
  • LGHL 0
  • Target Price
  • AZTR N/A
  • LGHL N/A
  • AVG Volume (30 Days)
  • AZTR 280.4K
  • LGHL 61.8K
  • Earning Date
  • AZTR 05-08-2025
  • LGHL 04-29-2025
  • Dividend Yield
  • AZTR N/A
  • LGHL N/A
  • EPS Growth
  • AZTR N/A
  • LGHL N/A
  • EPS
  • AZTR N/A
  • LGHL N/A
  • Revenue
  • AZTR $7,500.00
  • LGHL $13,659,110.00
  • Revenue This Year
  • AZTR N/A
  • LGHL N/A
  • Revenue Next Year
  • AZTR N/A
  • LGHL N/A
  • P/E Ratio
  • AZTR N/A
  • LGHL N/A
  • Revenue Growth
  • AZTR N/A
  • LGHL 11.24
  • 52 Week Low
  • AZTR $0.23
  • LGHL $2.82
  • 52 Week High
  • AZTR $12.00
  • LGHL $43.00
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 39.89
  • LGHL 32.32
  • Support Level
  • AZTR $0.28
  • LGHL $2.82
  • Resistance Level
  • AZTR $0.35
  • LGHL $4.89
  • Average True Range (ATR)
  • AZTR 0.03
  • LGHL 0.63
  • MACD
  • AZTR -0.00
  • LGHL -0.07
  • Stochastic Oscillator
  • AZTR 34.45
  • LGHL 25.37

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

About LGHL Lion Group Holding Ltd.

Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.

Share on Social Networks: